Archive

October 2025

Browsing

Homerun Resources Inc. (TSXV: HMR,OTC:HMRFF) (OTCQB: HMRFF) (‘Homerun’ or the ‘Company’) announces that the Company has submitted its formal application for conditional approval of the previously announced $6-million financing with a single institutional investor. The Company is now awaiting conditional approval from the TSX Venture Exchange.

The Company also reports, that further to its October 6, 2025, news release, the Company is oversubscribed for its $3-million unit private placement at $1.00. This financing will close after the above financing, as several subscribers have requested that the closing of the $6-million institutional financing be a precedent, and so the Company has requested and received approval from the TSX Venture Exchange to extend the closing of that financing for a standard 30-day period to November 24, 2025.

Both financings are anticipated to close in the immediate term, subject to TSX-V approval.

On behalf of the Board of Directors of
Homerun Resources Inc.

‘Brian Leeners’

Brian Leeners, CEO & Director
brianleeners@gmail.com / +1 604-862-4184 (WhatsApp)

Tyler Muir, Investor Relations
info@homerunresources.com / +1 306-690-8886 (WhatsApp)

FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE
The information contained herein contains ‘forward-looking statements’ within the meaning of applicable securities legislation. Forward-looking statements relate to information that is based on assumptions of management, forecasts of future results, and estimates of amounts not yet determinable. Any statements that express predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be ‘forward-looking statements’.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271921

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

This week began on a strong note, with emerging signs that US-China tensions could ease and White House Economic Advisor Kevin Hassett’s suggestion that the federal government shutdown could soon end.

US stocks rallied broadly, led by small caps and semiconductors, with the PHLX Semiconductor Sector (INDEXNASDAQ:SOX) hitting an all-time high amid reduced concerns about regional bank credit quality.

On Tuesday (October 21), hotter-than-expected Canadian inflation data weighed on the S&P/TSX Composite Index (INDEXTSI:OSPTX), while the Nasdaq Composite (INDEXNASDAQ:.IXIC) outperformed.

Wednesday (October 22) saw profit taking in high-growth names as Tesla (NASDAQ:TSLA) and IBM (NYSE:IBM) reported after the bell, and as reports of potential new US export curbs on China pressured equities.

IBM beat revenue forecasts with US$9.5 billion in artificial intelligence (AI) revenue, but offered cautious guidance, leading its share price to fall after-hours. Tesla missed revenue estimates, with margins falling to 5.8 percent due to price cuts and reduced regulatory credits, despite record deliveries. CEO Elon Musk reiterated medium-term goals in AI, autonomy and robotics, though the firm didn’t update its financial guidance. Tesla shares also dropped after hours.

Despite the pullback, the tech sector rebounded sharply on Thursday (October 23), driven by optimism about AI and cloud infrastructure. Quantum computing companies such as IonQ (NASDAQ:IONQ), Rigetti Computing (NASDAQ:RGTI) and D-Wave Quantum (NYSE:QBTS) surged on reports of increased US government funding.

North of the border, Canadian Prime Minister Mark Carney and Ontario Premier Doug Ford unveiled a C$3 billion joint investment in small modular reactors at the Darlington site, located east of Toronto in Bowmanville.

Later, Intel (NASDAQ:INTC) surpassed expectations with a 3 percent year-on-year revenue increase, reaching US$13.7 billion, with gross margins doubling to 38 percent. The demand for AI accelerators and x86 processors contributed to these strong results. CEO Lip-Bu Tan expressed confidence in continuing AI-driven compute demand.

Following the announcement, shares rose and opened nearly 5 percent higher the next day.

Intel’s standout earnings boosted sentiment heading into Friday. Markets opened higher after delayed US inflation data came in cooler than expected, showing easing underlying pressures and reinforcing expectations for another Fed rate cut next week. Tech stocks led the advance once again.

3 tech stocks that moved markets this week

1. Micron Technology (NASDAQ:MU)

Micron Technology shares rose 4.46 percent this week, hitting a record high above US$214 on Monday (October 20) after analysts at Barclays (NYSE:BCS) raised their price target from US$195 to US$240, citing robust earnings and margin expansion as signs of operational strength. The company has reported surging demand for its high-bandwidth memory chips, with supply fully sold out through 2026. Other semiconductor stocks, such as ON Semiconductor (NASDAQ:ON) and KLA (NASDAQ:KLAC), also gained, reflecting broad semiconductor strength.

2. Apple (NASDAQ:AAPL)

Apple’s share price is up 2.7 percent for the week, boosted by an overall bullish sentiment for high-value tech stocks, as well as momentum from strong M5 MacBook demand and solid sales of the iPhone 17 in the US and China.

CEO Tim Cook later announced the opening of the company’s Texas manufacturing facility on Thursday, two months ahead of schedule, further boosting sentiment.

3. NVIDIA (NASDAQ:NVDA)

Top AI stock NVIDIA saw gains of 1.67 percent this week following a joint announcement with Taiwan Semiconductor Manufacturing Company (NYSE:TSM). The companies said the first Blackwell wafer has been produced in the US at Taiwan Semiconductor’s semiconductor fab in Phoenix.

It is the first of its kind to be domestically manufactured in recent American history.

NVIDIA remains the bellwether for the AI sector, and its share price performance is widely regarded as a barometer for risk-on sentiment in the AI and tech sectors, with its share price movements often reflecting investor appetite for growth and optimism about the future of AI-driven innovation.

Micron Technology, NVIDIA and Apple performance, October 21 to 24, 2025.

Chart via Google Finance.

Tech ETF performance

This week, the iShares Semiconductor ETF (NASDAQ:SOXX) advanced by 1.83 percent, while the Invesco PHLX Semiconductor ETF (NASDAQ:SOXQ) saw a weekly gain of 1.91 percent.

The VanEck Semiconductor ETF (NASDAQ:SMH) increased by 1.59 percent.

Other tech market news

  • Amazon Web Services experienced a major outage this week, raising concerns about cloud infrastructure resilience and spotlighting the critical dependency on hyperscale providers.

        Tech news to watch next week

        Next week, investors will be eyeing interest rate decisions from the Bank of Canada and the US Federal Reserve. The Bank of Canada is expected to hold rates steady, reflecting ongoing cautiousness amid cooling inflation, while US investors are betting on a rate cut from the the country’s central bank.

        Earnings results from tech giants will also be closely watched, with Alphabet (NASDAQ:GOOGL), Microsoft and Meta reporting on Wednesday (October 29), and Apple and Amazon on Thursday (October 30).

        Strong beats or cautious guidance from these heavyweight companies could either boost confidence in the tech sector’s growth trajectory or temper enthusiasm in the final quarter of 2025.

        Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

        This post appeared first on investingnews.com

        Ed Steer of Ed Steer’s Gold and Silver Digest shares his thoughts on silver’s run past US$50 per ounce, saying that in his view the bull market is just getting started.

        ‘One way or another we’re going to run into a supply/demand brick wall, and when that day happens we could see triple-digit silver prices in a very, very short period of time,’ he said.

        Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

        This post appeared first on investingnews.com

        The gold price declined from its recent all-time highs this week, sinking to nearly US$4,000 per ounce and recording its biggest one-day decline in more than 12 years.

        Silver took a similar hit, slipping back below the US$50 per ounce level.

        The drops have been attributed to factors like a stronger US dollar and lower US-China tensions, as well as profit taking, potentially from traders who are new to the market.

        Many experts have been anticipating a correction for the metals — their latest rise has been quick, and no asset can go straight up forever.

        However, there’s also a broad consensus that gold has entered a new phase. For example, Patrick Tuohy of Goldstrom believes gold won’t fall below US$3,000 again.

        Here’s what Tuohy said:

        ‘Is this a short-term phenomenon that’s going to have some some dynamics that are going to turn it on its head and it reverses 50, 60 percent? I don’t believe that is the case. I think within our group … the consensus is that it’s unlikely that we’ll see gold below US$3,000 again in our lifetimes. So let’s say that that’s the floor. That’s a fairly significant move from where we were two years ago. So that’s comfortable.’

        Next week, all eyes will be on the US Federal Reserve, which is set to meet from October 28 to 29. CME Group’s (NASDAQ:CME) FedWatch tool shows strong expectations for another interest rate cut.

        While the release of US government data has been affected by the ongoing shutdown, September consumer price index numbers were released on Friday (October 24).

        The report was the first major piece of federal economic data to come out since the shutdown began, and it has confirmed expectations of another rate reduction.

        Bullet briefing — What’s next for gold and silver?

        Gold and silver prices perked up to end the week, rising to the US$4,100 and US$48.60 levels, respectively. But with the metals still off from their all-time highs, investors are wondering what’s next.

        Opinions vary, but I’ve pulled together a couple of quotes that illustrate what I’m hearing.

        First is Ed Steer of Ed Steer’s Gold and Silver Digest. He’s well known for his commentary on the precious metals space, and he weighed in on what’s next for silver, saying that today really is different compared to the other times silver rose to the US$50 level.

        Here’s how he explained it:

        ‘It’s irrelevant what the price is today. You look at the big picture, and look at the fact that the BRICS+ have become an absolutely awesome juggernaut, and it’s absolutely unstoppable. And as we shift from the west to the east, as this continues economically, financially, it’s impossible to say where this is going to end up.

        ‘But what we’re living right now is we’re living through a major, major shift in financial power, from one area of the world to another, and we’re going to be — they’re going to be writing about this 1,000 years from now. So we’re living through history.’

        Next we have Don Durrett of GoldStockData.com. This interview is from the week before last, so it’s a little older, but definitely still relevant. I’ve kept thinking about a comment Durrett made about one way we can tell the gold cycle is still early. This is what he said:

        The thing that really reveals how early we are is the stock market is only 2 percent from an all-time high. What in the world is the stock market doing at an all-time high and gold at an all-time high? Those are antagonistic. Gold is supposed to be a hedge against uncertainty. The stock market is supposed to show basically confidence.

        And so if you have an all-time high, people should be confident. Everything’s fine. We don’t need this. But people are not confident. People have said this is the most scary bull market ever. Nobody really believes in it, right? … So the question is, who’s telling the truth? Is the stock market telling the truth at an all time high, or is it gold is telling the truth? Well, it’s pretty obvious that gold’s the one telling the truth.

        In It To Win It interview

        Finally, if you’d like to hear more from me, I was recently interviewed by Steve Barton of In It To Win It.

        Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

        This post appeared first on investingnews.com

        Sun Summit Minerals Corp. (TSXV: SMN,OTC:SMREF) (OTCQB: SMREF) (‘Sun Summit’ or the ‘Company’) is pleased to announce that it will be attending and presenting at the 51st Annual New Orleans Investment Conference, taking place November 2–5, 2025 at the Hilton New Orleans Riverside.

        Niel Marotta, CEO and Director, will host a Sunrise Session presentation on Tuesday, November 4 at 7:15 AM (Churchill B2), where he will share updates on the Company’s flagship JD Project in British Columbia’s Toodoggone District, following the completion of a successful 2025 exploration season.

        Space is limited. Investors are invited to RSVP by October 31 to info@sunsummitminerals.com, and to visit Sun Summit at Booth #229 throughout the conference.

        The New Orleans Investment Conference brings together leading analysts, newsletter writers, and investors to discuss emerging opportunities across all major asset classes. Register today at https://neworleansconference.com/online-registration/.

        About the JD Project

        The JD Project is located in the Toodoggone mining district in north-central British Columbia, a highly prospective deposit-rich mineral trend. The project covers an area of over 15,000 hectares and is in close proximity to active exploration and development projects, such as Thesis Gold’s Lawyers and Ranch projects, TDG Gold’s Baker-Shasta projects, Amarc Resource’s AuRORA project, Centerra’s Gold’s Kemess East and Underground projects, as well as the past-producing Kemess open pit copper-gold mine.

        The project is 450 kilometres northwest of the city of Prince George, and 25 kilometres north of the Sturdee airstrip. It is proximal to existing infrastructure in place to support the past-producing Kemess mine, including roads and a hydroelectric power line.

        The JD Project is in a favourable geological environment characterized by both high-grade epithermal gold and silver mineralization, as well as porphyry-related copper and gold mineralization. Some historical exploration, including drilling, geochemistry and geophysics, has been carried out on the property, however the project area is largely underexplored.

        About Sun Summit

        Sun Summit Minerals (TSXV: SMN,OTC:SMREF) (OTCQB: SMREF) is a mineral exploration company focused on the discovery, expansion and advancement of district-scale gold and copper assets in British Columbia. The Company’s diverse portfolio includes its flagship JD Project and the nearby Theory Project in the Toodoggone region of north-central B.C., as well as the Buck Project in central B.C.

        Further details are available at www.sunsummitminerals.com.

        On behalf of the board of directors

        Niel Marotta
        Chief Executive Officer & Director
        info@sunsummitminerals.com

        For further information, contact:

        Matthew Benedetto, Simone Capital
        mbenedetto@simonecapital.ca
        Tel. 416-817-1226

        Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

        Forward-Looking Statements

        Statements contained in this news release that are not historical in nature may be ‘forward-looking information’ within the meaning of applicable Canadian securities legislation (‘forward-looking statements ‘), which involve risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements, by their nature, require Sun Summit to make certain assumptions and necessarily involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in these forward-looking statements. Forward-looking statements are not guarantees of performance. Words such as ‘may’, ‘will’, ‘would’, ‘could’, ‘expect’, ‘believe’, ‘plan’, ‘anticipate’, ‘intend’, ‘estimate’, ‘continue’, ‘objective’, ‘strategy’, or the negative or comparable terminology, as well as terms usually used in the future and the conditional, are intended to identify forward-looking statements. Information contained in forward-looking statements is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including the assumptions, qualifications, limitations or statements relating to the pending results of the drill holes, the success of the exploration program, the impressive results of the drill campaign, the ability of exploration activities (including drilling) to accurately predict mineralization, future drill programs and high-priority targets, our timing and ability to receive assay results, the reliability of historical information that cannot be independently verified by Sun Summit, interests in the JD Project, errors in geological modelling, and the adjacent properties having any significance to the projects in which Sun Summit has an interest. There is significant risk that the forward-looking statements will not prove to be accurate, that the management’s assumptions may not be correct and that actual results may differ materially from such forward-looking statements. These forward-looking statements are based on a number of assumptions which may prove to be incorrect which, without limiting the generality of the following, include: the Company’s ability to obtain assay results for the completed drill program; the anticipated results varying from current indications, including the already released drill results; risks inherent in exploration activities; volatility and sensitivity to market prices; volatility and sensitivity to capital market fluctuations; and fluctuations in metal prices. Accordingly, readers should not place undue reliance on the forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof or the dates specifically referenced in this news release, where applicable. Except as required by applicable securities laws and regulation, Sun Summit disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. All forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

        To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271649

        News Provided by Newsfile via QuoteMedia

        This post appeared first on investingnews.com

        /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./

        Quimbaya Gold Inc. (‘Quimbaya’ or the ‘Company’) (CSE: QIM,OTC:QIMGF) (OTCQB: QIMGF) (FSE: K05) is pleased to announce that it has entered into an agreement with Stifel Canada to act as sole underwriter and bookrunner (the ‘Underwriter’), in connection with a ‘bought deal’ private placement of 14,300,000 units of the Company  (the ‘LIFE Units’) at a price of C$0.70 per LIFE Unit (the ‘Offering Price’) for aggregate gross proceeds of C$10,010,000 (the ‘Offering’), with the LIFE Units to be issued pursuant to the Listed Issuer Financing Exemption (as defined below). 

        The Company has granted to the Underwriter an option, exercisable up to 48 hours prior to the closing date, to purchase for resale up to an additional 15% of LIFE Units at the Offering Price for additional gross proceeds of up to C$1,501,500

        Each LIFE Unit will consist of one common share (a ‘Common Share‘) and one-half (½) of one Common Share purchase warrant (each whole warrant, a ‘Warrant‘) of the Company. Each Warrant will be exercisable to acquire one Common Share for a period of 36 months following the closing date of the Offering at an exercise price of C$1.00 per common share.

        The net proceeds from the Offering are expected to be used to advance the Company’s exploration programs, including drilling at the Tahami South project and follow-up work on regional copper-gold and gold targets, as well as for general working capital.

        Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 – Prospectus Exemptions (‘NI 45-106‘), the LIFE Units will be offered for sale to purchasers resident in Canada other than Quebec and/or other qualifying jurisdictions pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the ‘Listed Issuer Financing Exemption‘). Because the Offering is being completed pursuant to the Listed Issuer Financing Exemption, the LIFE Units issued pursuant to the Offering will not be subject to a hold period pursuant to applicable Canadian securities laws. There is an offering document related to the Offering that can be accessed under the Company’s issuer profile on SEDAR+ at www.sedarplus.ca and on the Company’s website at quimbayagold.com. Prospective investors should read the offering document before making an investment decision.

        The Offering is scheduled to close on or about November 4, 2025 (the ‘Closing Date‘) and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals including the acceptance of the Canadian Securities Exchange.

        The securities referred to in this news release have not been and will not be registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act‘), or any state securities laws and may not be offered or sold within the United States or to, or for the account or benefit of, ‘U.S. Persons’ (as such term is defined in Regulation S under the U.S. Securities Act) absent such registration or an applicable exemption from the registration requirements of the U.S. Securities Act. This news release does not constitute an offer for sale of securities for sale, nor a solicitation for offers to buy any securities. Any public offering of securities in the United States must be made by means of a prospectus containing detailed information about the company and management, as well as financial statements.

        About Quimbaya 

        Quimbaya aims to discover gold resources through exploration and acquisition of mining properties in the prolific gold mining districts of Colombia. Managed by an experienced team in the mining sector, Quimbaya is focused on three projects in the regions of Segovia (Tahami Project), Puerto Berrio (Berrio Project), and Abejorral (Maitamac Project), all located in Antioquia Province, Colombia.

        Quimbaya Gold Inc.

        Follow on X @quimbayagoldinc
        Follow on LinkedIn @quimbayagold
        Follow on YouTube @quimbayagoldinc
        Follow on Instagram @quimbayagoldinc
        Follow on Facebook @quimbayagoldinc

        Cautionary Statements

        Certain statements contained in this press release constitute ‘forward-looking information’ as that term is defined in applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information. Generally, but not always, forward-looking statements and information can be identified by the use of forward-looking terminology such as ‘intends’, ‘expects’ or ‘anticipates’, or variations of such words and phrases or statements that certain actions, events or results ‘may’, ‘could’, ‘should’, ‘would’ or ‘occur’. Forward-looking statements herein include statements and information regarding the closing of the Offering, Offering’s intended use of proceeds, any exercise of Warrants, the future plans for the Company, including any expectations of growth or market momentum, future expectations for the gold sector generally, the Colombian gold sector more particularly, or how global or local market trends may affect the Company, intended exploration on any of the Company’s properties and any results thereof, the strength of the Company’s mineral property portfolio, the potential discovery and potential size of the discovery of minerals on any property of the Company’s, including Tahami South, the aims and goals of the Company, and other forward-looking information. Forward-looking information by its nature is based on assumptions and involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Quimbaya to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. These assumptions include, but are not limited to, that the Company’s exploration and other activities will proceed as expected. The future outcomes that relate to forward-looking statements may be influenced by many factors, including but not limited to: future planned development and other activities on the Company’s mineral properties; an inability to finance the Company; obtaining required permitting on the Company’s mineral properties in a timely manner; any adverse changes to the planned operations of the Company’s mineral properties; failure by the Company for any reason to undertake expected exploration programs; achieving and maintaining favourable relationships with local communities; mineral exploration results that are poorer or better than expected; prices for gold remaining as expected; currency exchange rates remaining as expected; availability of funds for the Company’s projects; prices for energy inputs, labour, materials, supplies and services (including transportation); no labour-related disruptions; no unplanned delays or interruptions in scheduled construction and production; all necessary permits, licenses and regulatory approvals are received in a timely manner; the Offering proceeds being received as anticipated; all requisite regulatory and stock exchange approvals for the Offering are obtained in a timely fashion; investor participation in the Offering; and the Company’s ability to comply with environmental, health and safety laws. Although Quimbaya’s management believes that the assumptions made and the expectations represented by such information are reasonable, there can be no assurance that the forward-looking information will prove to be accurate. Furthermore, should one or more of the risks, uncertainties or other factors materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking statements or information. Readers are cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement. The forward-looking information contained in this news release represents the expectations of Quimbaya as of the date of this news release and, accordingly, is subject to change after such date. Except as required by law, Quimbaya does not expect to update forward-looking statements and information continually as conditions change.

        SOURCE Quimbaya Gold Inc.

        View original content: http://www.newswire.ca/en/releases/archive/October2025/23/c7762.html

        News Provided by Canada Newswire via QuoteMedia

        This post appeared first on investingnews.com

        Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector is home to companies pursuing cutting-edge therapies and medical technologies.

        Read on to learn what’s been driving these Canadian biotech firms.

        1. Eupraxia Pharmaceuticals (TSX:EPRX)

        Year-on-year gain: 141.23 percent
        Market cap: C$410.85 million
        Share price: C$8.25

        Eupraxia Pharmaceuticals is developing clinical candidates that employ its DiffuSphere technology, which delivers treatments to the targeted tissues.

        The company’s candidates are currently EP-104GI for eosinophilic esophagitis and EP-104IAR for knee osteoarthritis, and it is exploring the use of its technology for other active compounds as well.

        Eupraxia added EP-104GI to its pipeline through its acquisition of EpiPharma Therapeutics in late 2023. The company has continued to advance the treatment through clinical trials in 2025 and released multiple rounds of positive data from its Phase 1b/2a trial cohorts.

        In July, Eupraxia dosed its first patient after advancing its investigation to Phase 2b trials based on safety and efficacy data from the earlier Phase 2a patient cohorts. Top-line results from the Phase 2b study are anticipated in the second half of 2026.

        In September, the company shared data from the highest-dose cohort of the still ongoing Phase 1b/2a trials, reporting that the group saw the largest improvements so far.

        2. Bright Minds Biosciences (CSE:DRUG)

        Year-on-year gain: 103.17 percent
        Market cap: C$683.67 million
        Share price: C$92.95

        Bright Minds Biosciences is developing novel serotonin agonists targeting neurocircuit abnormalities linked to neuropsychiatric disorders and epilepsy, designing next-generation treatments that aim to retain the therapeutic benefits of psychedelics while minimizing side effects.

        Its lead candidate, BMB-101, a selective 5-HT2C receptor agonist, has shown encouraging preclinical efficacy by stopping seizures in an epilepsy mouse model, evaluated jointly with Firefly Neuroscience (NASDAQ:AIFF).

        The company’s stock surged nearly 1,500 percent in October 2024 following H. Lundbeck’s acquisition announcement of a competitor focused on similar targets. Strengthening its epilepsy expertise, Bright Minds expanded its scientific advisory board in early 2025 by adding five leaders in the field.

        Ongoing clinical progress and strategic growth initiatives position Bright Minds as a promising contender in the neuropsychiatric treatment landscape.

        3. Hemostemix (TSXV:HEM)

        Year-on-year gain: 31.25 percent
        Market cap: C$18.40 million
        Share price: C$0.11

        Hemostemix is a clinical-stage biotech company focused on developing autologous stem cell therapies, meaning the treatments use a patient’s own cells to theoretically enhance safety and efficacy.

        Its main product, ACP-01, is an autologous cell therapy designed to promote tissue repair and regeneration in areas affected by diseases, including a range of heart diseases.

        The company announced its first advanced sales orders for ACP-01 in Q1 2025 and has been working to expand internationally and attract new investment.

        Hemostemix secured the regulatory green light for commercial sales in Florida after the state passed Senate Bill 1768. The bill creates a framework in which healthcare providers can administer stem cell therapies that had not yet been approved by the US Food and Drug Administration (FDA) but meet the bill’s guidelines.

        The company now offers commercial ACP-01 treatments for ischemic pain in the state under the name VesCell, with sales forecasted to reach C$22.5 million in 2026. Operational plans target cash flow positivity by Q4 2026, supported by a growing physician network and commercial pipeline.

        Additionally, Hemostemix is currently collaborating with Firefly Neuroscience on a Phase 1 clinical trial of ACP-01 for vascular dementia.

        4. NervGen (TSXV:NGEN)

        Year-on-year gain: 79.92 percent
        Market cap: C$300.97 million
        Share price: C$4.39

        NervGen is a clinical-stage Canadian biotechnology company that focuses on developing innovative treatments to enable the nervous system to repair itself following damage from injury or disease.

        The company’s core technology targets a mechanism that hinders nervous system repair. When the nervous system is damaged, chondroitin sulfate proteoglycans (CSPG) form a “scar.” Initially, CSPGs help contain damage, but their long-term interaction with the PTPσ receptor inhibits repair.

        NervGen’s lead drug candidate, NVG-291, is designed to relieve these inhibitory effects to promote nervous system repair. It received fast-track designation from the US FDA.

        NervGen is advancing NVG-291 in a Phase 1b/2a clinical trial for spinal cord injury (SCI) and reported positive data from the chronic cohort in June.

        NVG-300, a newer preclinical candidate, is being evaluated for ischemic stroke and SCI.

        Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

        This post appeared first on investingnews.com

        Investor and author Gianni Kovacevic discusses silver’s price pullback, saying that in the long term he sees the white metal reaching triple digits.

        He expects oil prices to reach that level too, but emphasized that he sees lithium as the truly contrarian play for the rest of 2025 and into next year.

        Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

        This post appeared first on investingnews.com